Opinion

Video

Evidence-Based Sequencing for HER2+ mBC After Progression: Clinical Trial Data and NCCN Guideline Updates

Key opinion leaders explore various therapeutic options for later-line treatment of HER2-positive metastatic breast cancer, emphasizing the significance of the HER2CLIMB and CLEOPATRA trials, while also drawing comparisons to real-world data to inform clinical decision-making.

Related Videos
2 KOLs are featured in this program.
2 KOLs are featured in this program.
Shipra Gandhi, MD
2 KOLs are featured in this series
2 KOLs are featured in this series
A panel of 5 experts on breast cancer
A panel of 5 experts on breast cancer
2 KOLs are featured in this series
Sheldon M. Feldman, MD
Rita Mukhtar, MD